Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China
From 2017 to 2018, Guangzhou experienced a shortage in 3–6 types of National Immunization Program (NIP) vaccines. To evaluate the current situation and causes of the NIP vaccine shortage, we analysed the duration, intensity and causes of the shortage from data in the vaccine information system of th...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2019.1644883 |
| _version_ | 1797677352309751808 |
|---|---|
| author | Zhiqun Li Jindong Xu Jianxiong Xu Huifeng Tan Chunhuan Zhang |
| author_facet | Zhiqun Li Jindong Xu Jianxiong Xu Huifeng Tan Chunhuan Zhang |
| author_sort | Zhiqun Li |
| collection | DOAJ |
| description | From 2017 to 2018, Guangzhou experienced a shortage in 3–6 types of National Immunization Program (NIP) vaccines. To evaluate the current situation and causes of the NIP vaccine shortage, we analysed the duration, intensity and causes of the shortage from data in the vaccine information system of the Guangzhou Center for Disease Control and Prevention; we also proposed countermeasures to resolve the shortage. In 2017, there were shortages of three types of NIP vaccines in Guangzhou. The most affected vaccines were inactivated poliovirus (IPV) vaccine and meningococcal group AC (MenAC) vaccine, accounting for 39.5% and 16.5% of the reported shortages, respectively. In 2018, the shortage extended to six vaccine types; the most affected were diphtheria, tetanus and pertussis (DTP) vaccine, MenAC vaccine, and Bacille Calmette Guerin (BCG) vaccine. The four main causes for the shortage were: 1) an insufficient production capacity; 2) a delay in batch issuance; 3) vaccine-related events; and 4) an extended bidding procurement cycle. Four solutions are proposed: 1) expand production output; 2) exempt creditworthy enterprises from batch inspections; 3) establish alternative enterprises and emergency use authorizations; and 4) establish public health funds and stockpile storage systems. |
| first_indexed | 2024-03-11T22:43:50Z |
| format | Article |
| id | doaj.art-86608e53d9a74e6fa0f969f07b7938b0 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:43:50Z |
| publishDate | 2020-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-86608e53d9a74e6fa0f969f07b7938b02023-09-22T08:45:32ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2020-01-01161767910.1080/21645515.2019.16448831644883Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, ChinaZhiqun Li0Jindong Xu1Jianxiong Xu2Huifeng Tan3Chunhuan Zhang4Guangzhou Center For Disease Control And PreventionGuangdong Provincial People’s Hospital & Guangdong Academy of Medical SciencesGuangzhou Center For Disease Control And PreventionGuangzhou Center For Disease Control And PreventionGuangzhou Center For Disease Control And PreventionFrom 2017 to 2018, Guangzhou experienced a shortage in 3–6 types of National Immunization Program (NIP) vaccines. To evaluate the current situation and causes of the NIP vaccine shortage, we analysed the duration, intensity and causes of the shortage from data in the vaccine information system of the Guangzhou Center for Disease Control and Prevention; we also proposed countermeasures to resolve the shortage. In 2017, there were shortages of three types of NIP vaccines in Guangzhou. The most affected vaccines were inactivated poliovirus (IPV) vaccine and meningococcal group AC (MenAC) vaccine, accounting for 39.5% and 16.5% of the reported shortages, respectively. In 2018, the shortage extended to six vaccine types; the most affected were diphtheria, tetanus and pertussis (DTP) vaccine, MenAC vaccine, and Bacille Calmette Guerin (BCG) vaccine. The four main causes for the shortage were: 1) an insufficient production capacity; 2) a delay in batch issuance; 3) vaccine-related events; and 4) an extended bidding procurement cycle. Four solutions are proposed: 1) expand production output; 2) exempt creditworthy enterprises from batch inspections; 3) establish alternative enterprises and emergency use authorizations; and 4) establish public health funds and stockpile storage systems.http://dx.doi.org/10.1080/21645515.2019.1644883nip vaccineshortagecauseinventory reservecountermeasures |
| spellingShingle | Zhiqun Li Jindong Xu Jianxiong Xu Huifeng Tan Chunhuan Zhang Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China Human Vaccines & Immunotherapeutics nip vaccine shortage cause inventory reserve countermeasures |
| title | Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China |
| title_full | Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China |
| title_fullStr | Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China |
| title_full_unstemmed | Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China |
| title_short | Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China |
| title_sort | current situation causes and countermeasures to nip vaccine shortages in guangzhou china |
| topic | nip vaccine shortage cause inventory reserve countermeasures |
| url | http://dx.doi.org/10.1080/21645515.2019.1644883 |
| work_keys_str_mv | AT zhiqunli currentsituationcausesandcountermeasurestonipvaccineshortagesinguangzhouchina AT jindongxu currentsituationcausesandcountermeasurestonipvaccineshortagesinguangzhouchina AT jianxiongxu currentsituationcausesandcountermeasurestonipvaccineshortagesinguangzhouchina AT huifengtan currentsituationcausesandcountermeasurestonipvaccineshortagesinguangzhouchina AT chunhuanzhang currentsituationcausesandcountermeasurestonipvaccineshortagesinguangzhouchina |